Canada Pension Plan Investment Board’s TG Therapeutics TGTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Sell	4,400 -3,500	-44%	-$143K	﹤0.01%	1543
2026 Q1	$262K	Buy	+7,900	New	+$235K	﹤0.01%	1476
2024 Q3	–	Sell	-1,500	Closed	-$26.7K	–	1467
2024 Q2	$26.7K	Sell	1,500 -43,500	-97%	-$694K	﹤0.01%	1314
2024 Q1	$684K	Buy	+45,000	New	+$717K	﹤0.01%	1077
2020 Q3	–	Sell	-28,000	Closed	-$545K	–	1351
2020 Q2	$545K	Buy	+28,000	New	+$451K	﹤0.01%	1053

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Canada Pension Plan Investment Board's TGTX Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its TG Therapeutics (TGTX) stake by 44% in Q2 2026, selling an estimated $143K and leaving 4,400 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

Canada Pension Plan Investment Board first reported a position in TGTX in Q2 2020 and has held it in 5 quarters since. The position peaked at $684K in Q1 2024. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Canada Pension Plan Investment Board held 4,400 shares of TG Therapeutics worth $242K as of Q2 2026.
Canada Pension Plan Investment Board sold 3,500 TG Therapeutics shares in Q2 2026, an estimated $143K.
TG Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1543 holding.
Canada Pension Plan Investment Board first reported a position in TG Therapeutics in Q2 2020 and has held it in 5 quarters since.
Canada Pension Plan Investment Board's TG Therapeutics position peaked at $684K in Q1 2024.
430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.